Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. SC 13G Stake Amended Statement of Ownership
  5. 8-K Event Regulation FD disclosure
  6. 4 Open-market buy Director bought 25,000 shares at an average $2.28 ($56,928)
  7. 4 Open-market buy Vice President, Manufacturing bought 11,000 shares at $2.25 ($24,749)
  8. 4 Open-market buy CEO and Director bought 69,000 shares at $2.20 ($151,662)
  9. 4 Open-market buy Director bought 50,000 shares at an average $2.48 ($123,885)
  10. 8-K Event Regulation FD disclosure · Other events
  11. 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 8-K Event Regulation FD disclosure
  15. SC 13G/A Stake Amended Statement of Ownership
  16. 8-K Event Regulation FD disclosure · Other events
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 28 of 38 · 755 filings